Seeing Is Believing
CRSP is currently covered by 23 analysts with an average price target of $58.65. This is a potential upside of $26 (79.63%) from yesterday's end of day stock price of $32.65.
Crispr Therapeutics AG's activity chart (see below) currently has 213 price targets and 217 ratings on display. The stock rating distribution of CRSP is 62.35% BUY, 28.24% HOLD and 9.41% SELL.
Analysts average stock forecasts to be materialized ratio is 56.71% with an average time for these price targets to be met of 94.7 days.
Highest price target for CRSP is $105, Lowest price target is $32, average price target is $74.8.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Feb-2025. First documented stock forecast 14-Nov-2016.
Currently out of the existing stock ratings of CRSP, 53 are a BUY (62.35%), 24 are a HOLD (28.24%), 8 are a SELL (9.41%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$82
$45.01 (121.68%)
$84
1 months 17 days ago
(18-Feb-2025)
11/18 (61.11%)
$32.28 (64.92%)
196
Sell
$32
$-4.99 (-13.49%)
$30
1 months 17 days ago
(18-Feb-2025)
7/9 (77.78%)
$-17.72 (-35.64%)
283
Hold
$99
$62.01 (167.64%)
$60
1 months 17 days ago
(18-Feb-2025)
1/4 (25%)
$49.28 (99.12%)
29
Buy
$65
$28.01 (75.72%)
$65
1 months 22 days ago
(13-Feb-2025)
0/2 (0%)
$21.51 (49.46%)
Buy
$86
$49.01 (132.50%)
$86
1 months 22 days ago
(13-Feb-2025)
12/16 (75%)
$42.51 (97.75%)
161
What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?
Which analyst has the current highest performing score on CRSP (Crispr Therapeutics AG) with a proven track record?
Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?
Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?